FDA approves new drug that may help stop and even reverse a rare, fatal condition that doctors call a ‘ticking time bomb’ – CNN

FDA approves new drug that may help stop and even reverse a rare, fatal condition that doctors call a ‘ticking time bomb’ CNNFDA approves Merck’s drug for rare, deadly lung condition CNBCFDA Approves Potential ‘Game Changer’ for Pulmonary Arterial Hypertension BioSpaceFDA Approves Merck’s WINREVAIR™ (sotatercept-csrk), a First-in-Class Treatment for Adults with Pulmonary Arterial Hypertension (PAH, WHO* Group 1) MerckMerck’s $11.5 Billion Bet on Its Next Big Drug Finally Arrives The Wall Street Journal